Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.40
+2.30 (3.23%)
At close: Aug 20, 2025, 1:25 PM CST

Pet Pharm Biotech Revenue

In the year 2024, Pet Pharm Biotech had annual revenue of 130.70M TWD with 10.89% growth.

Revenue
130.70M
Revenue Growth
+10.89%
P/S Ratio
28.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024130.70M12.83M10.89%
Dec 31, 2023117.87M42.13M55.62%
Dec 31, 202275.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition